Aytu BioPharma
Stock Forecast, Prediction & Price Target

Aytu BioPharma Financial Estimates

Aytu BioPharma Revenue Estimates

Aytu BioPharma EBITDA Estimates

Aytu BioPharma Earnings per Share Estimates

Passed Analyst forecast
Metric 6/30/2022 6/30/2023 6/30/2024 6/30/2026 6/30/2027
Revenue
 
% change YoY
$96.66M
 
N/A
$107.39M
 
11.09%
$81.00M
 
-24.57%
Avg: $71.57M
Low: $71.57M
High: $71.57M
avg. -11.63%
Avg: $117.7M
Low: $117.7M
High: $117.7M
avg. 64.43%
Net Income
 
% change YoY
$-110.17M
 
N/A
$-17.05M
 
84.52%
$-15.84M
 
7.07%
Avg: $662K
Low: $367.38K
High: $367.38K
avg. 104.17%
Avg: $-1.06M
Low: $-1.06M
High: $-1.06M
avg. -261.44%
EBITDA
 
% change YoY
$41.28M
 
N/A
$-3.51M
 
-108.51%
$-1.01M
 
71.20%
Avg: $-19.35M
Low: $-19.35M
High: $-19.35M
avg. -1812.65%
Avg: $-31.82M
Low: $-31.82M
High: $-31.82M
avg. -64.43%
EPS
 
% change YoY
-$74.95
 
N/A
-$5.11
 
93.18%
-$2.86
 
44.03%
Avg: $0.11
Low: $0.11
High: $0.11
avg. 103.84%
Avg: -$0.32
Low: -$0.32
High: -$0.32
avg. -390.90%
Operating Expenses
 
% change YoY
$88.38M
 
N/A
$78.96M
 
-10.66%
$60.57M
 
-23.29%
Avg: $87.51M
Low: $87.51M
High: $87.51M
avg. 44.49%
Avg: $143.91M
Low: $143.91M
High: $143.91M
avg. 64.43%

FAQ

What is Aytu BioPharma stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -78.63% in 2026-2027.

We have gathered data from 1 analysts. Their low estimate is 367.38K, average is 662K and high is 367.38K.

What is Aytu BioPharma stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 26.40% in 2026-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $71.57M, average is $71.57M and high is $71.57M.

What is Aytu BioPharma stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -143.53% in 2026-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is $0.11, average is $0.11 and high is $0.11.